Bioceres Crop Solutions's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 347.84.
Bioceres Crop Solutions's Days Inventory for the
three
months ended in Mar. 2026 was 214.62.
Bioceres Crop Solutions's Days Payable for the
three
months ended in Mar. 2026 was 290.1.
Therefore, Bioceres Crop Solutions's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 272.36.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Bioceres Crop Solutions Cash Conversion Cycle Related Terms
Bioceres Crop Solutions Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Bioceres Crop Solutions's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIOX vs GNVR, PUBC, SEED: Cash Conversion Cycle Comparison
For the Agricultural Inputs subindustry, Bioceres Crop Solutions's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioceres Crop Solutions Cash Conversion Cycle vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Bioceres Crop Solutions's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Bioceres Crop Solutions's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Bioceres Crop Solutions's Cash Conversion Cycle for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioceres Crop Solutions (BIOX) has a Cash Conversion Cycle of 272.36 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Bioceres Crop Solutions and its competitors.
Is Bioceres Crop Solutions' Cash Conversion Cycle too high?
Bioceres Crop Solutions' current Cash Conversion Cycle is 272.36. The Agriculture industry median Cash Conversion Cycle is 99.32. Bioceres Crop Solutions' value of 272.36 is 174.2% above this industry median. Overall, Bioceres Crop Solutions has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bioceres Crop Solutions' Cash Conversion Cycle compare to GNVR and PUBC?
Bioceres Crop Solutions' Cash Conversion Cycle of 272.36 can be compared against companies in the Agriculture industry. The industry median Cash Conversion Cycle is 99.32. Bioceres Crop Solutions' value of 272.36 is 174.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Agriculture company?
The median Cash Conversion Cycle among Agriculture companies is 99.32, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioceres Crop Solutions's current Cash Conversion Cycle of 272.36 is 174.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Bioceres Crop Solutions and its competitors. For the Agriculture industry, the median Cash Conversion Cycle is 99.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioceres Crop Solutions's current Cash Conversion Cycle is 272.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioceres Crop Solutions stock overvalued right now?
Based on GuruFocus' analysis, Bioceres Crop Solutions (BIOX) is currently considered Possible Value Trap. The stock's GF Value™ is $4.79, compared to a current price of $0.36 — trading 92.5% below its estimated fair value. The current Cash Conversion Cycle is 272.36 and 174.2% above the Agriculture industry median of 99.32. Bioceres Crop Solutions' overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Bioceres Crop Solutions (BIOX), the current Cash Conversion Cycle is 272.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioceres Crop Solutions (BIOX) Overvalued in 2026?
Based on GuruFocus' analysis, Bioceres Crop Solutions stock appears to be undervalued.
The current stock price of $0.36 is trading 92.5% below its estimated GF Value™ of $4.79.
GuruFocus considers Bioceres Crop Solutions to be Possible Value Trap.
Key valuation signals for BIOX:
Cash Conversion Cycle: 272.36
GF Value™: $4.79 vs. price of $0.36 (92.5% below fair value)
Industry Position: 174.2% above the Agriculture median
No single metric tells the full story. See the BIOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
56GF Score
Get the complete analysis for BIOX
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOX has been successfully added to your 
